A custom virtual reality training solution for ophthalmologic surgical clinical trials | Advances in Simulation | Full Text
Port Delivery System with ranibizumab (PDS) implant. A, Port Delivery... | Download Scientific Diagram
Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration - Vladimir Bantseev, Joshua Horvath, Giulio Barteselli ...
Ophthalmology Management - SUSTAINED ANTI-VEGF DELIVERY
Use of the Port Delivery System in AMD - Retina Today
Optometric Management - July 2020
The promise of PDS in real-world practice
Retinal Physician - The Port Delivery System With Ranibizumab
Evaluation of Port Delivery System with ranibizumab for the treatment of neovascular age-related macular degeneration | Therapeutic Delivery
Retina Global - Vision outcomes using a port delivery system proved equivalent to ranibizumab injections and showed a positive benefit profile. #PDS #nAMD #antiVEGF http://bit.ly/3nqW8aS | Facebook
Long-Acting Anti-VEGF Delivery
How SUSVIMO™ (ranibizumab injection) Works for nAMD
Port Delivery System - EyeWiki
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial - ScienceDirect
Genentech reports positive Phase II data of Port Delivery System
Long-Acting Anti-VEGF Delivery
Implanted drug 'reservoir' safely reduces inj | EurekAlert!
Figure of the port delivery system (PDS) implant with dimensions of... | Download Scientific Diagram
In-vitro characterization of ranibizumab release from the Port Delivery System - ScienceDirect
New implant technology safely minimizes injections for people with macular degeneration
Adverse effects of the implantable ranibizumab system may undermine its benefits - American Academy of Ophthalmology
Targeting Unmet Needs in nAMD Treatment
Refill-Exchange Procedure of the Port Delivery System With Ranibizumab: Overview and Clinical Trial Experience | Ophthalmic Surgery, Lasers and Imaging Retina
Ophthalmology Management - SUSTAINED ANTI-VEGF DELIVERY
Archway phase 3 trial of the Port Delivery System with ranibizumab (PDS) for neovascular AMD: end-of-study results
